DNA origami/gold nanorod hybrid nanostructures for the circumvention of drug resistance

被引:106
作者
Song, Linlin [1 ,2 ,3 ]
Jiang, Qiao [1 ]
Liu, Jianbing [1 ]
Li, Na [1 ]
Liu, Qing [1 ,3 ]
Dai, Luru [1 ]
Gao, Yuan [4 ]
Liu, Weili [4 ]
Liu, Dongsheng [2 ]
Ding, Baoquan [1 ,3 ]
机构
[1] Natl Ctr Nanosci & Technol, CAS Ctr Excellence Nanosci, CAS Key Lab Nanosyst & Hierarch Fabricat, 11 BeiYiTiao, Beijing 100190, Peoples R China
[2] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Organ Optoelect & Mol Engn, Beijing 100084, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] Beijing Ctr Phys & Chem Anal, Beijing 100089, Peoples R China
基金
北京市自然科学基金;
关键词
MULTIDRUG-RESISTANCE; BIOMEDICAL APPLICATIONS; CANCER-THERAPY; DELIVERY; NANOPARTICLES; THERAPEUTICS; TRANSPORTERS; CHEMOTHERAPY; INSIGHTS; COMPLEX;
D O I
10.1039/c7nr02222k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We herein demonstrate that DNA origami can work as a multifunctional platform integrating a chemotherapeutic drug (doxorubicin), gold nanorods and a tumour-specific aptamer MUC-1, to realize the effective circumvention of drug resistance. Doxorubicin (DOX) was loaded efficiently onto DNA origami through base pair intercalation and surface-modified gold nanorods (AuNRs) were assembled onto the DNA origami through DNA hybridization. Due to the active targeting effect of the assembled aptamers, the multifunctional nanostructures achieved increased cellular internalization of DOX and AuNRs. Upon near-infrared (NIR) laser irradiation, the P-glycoprotein (multidrug resistance pump) expression of multidrug resistant MCF-7 (MCF-7/ADR) cells was down-regulated, achieving the synergistically chemotherapeutic (DOX) and photothermal (AuNRs) effects.
引用
收藏
页码:7750 / 7754
页数:5
相关论文
共 35 条
[1]   Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine [J].
Ali, M. Monsur ;
Li, Feng ;
Zhang, Zhiqing ;
Zhang, Kaixiang ;
Kang, Dong-Ku ;
Ankrum, James A. ;
Le, X. Chris ;
Zhao, Weian .
CHEMICAL SOCIETY REVIEWS, 2014, 43 (10) :3324-3341
[2]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[3]   Aptamer-Conjugated DNA Icosahedral Nanoparticles As a Carrier of Doxorubicin for Cancer Therapy [J].
Chang, Microsugar ;
Yang, Chung-Shi ;
Huang, Dong-Ming .
ACS NANO, 2011, 5 (08) :6156-6163
[4]   Physical and Biochemical Insights on DNA Structures in Artificial and Living Systems [J].
Chen, Nan ;
Li, Jiang ;
Song, Haiyun ;
Chao, Jie ;
Huang, Qing ;
Fan, Chunhai .
ACCOUNTS OF CHEMICAL RESEARCH, 2014, 47 (06) :1720-1730
[5]   Nanoparticle therapeutics: an emerging treatment modality for cancer [J].
Davis, Mark E. ;
Chen, Zhuo ;
Shin, Dong M. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :771-782
[6]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[7]  
Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
[8]   The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect [J].
Fang, Jun ;
Nakamura, Hideaki ;
Maeda, Hiroshi .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :136-151
[9]   ABC transporters in cancer: more than just drug efflux pumps [J].
Fletcher, Jamie I. ;
Haber, Michelle ;
Henderson, Michelle J. ;
Norris, Murray D. .
NATURE REVIEWS CANCER, 2010, 10 (02) :147-156
[10]   Multidrug resistance in cancer: Role of ATP-dependent transporters [J].
Gottesman, MM ;
Fojo, T ;
Bates, SE .
NATURE REVIEWS CANCER, 2002, 2 (01) :48-58